A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...

Doctor, doctor, give me the news, Hims & Hers Health (HIMS) has got bad case of the stock market blues. The San Francisco ...

Hims & Hers (NYSE:HIMS) fell ~8% in the premarket Thursday after a federal judge denied a motion filed by a compounding trade ...

This shortage is the essential thing permitting drug compounders like OFA (and Hims & Hers Health, too) to make and sell ...

Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

BofA notes that Judge Mark Pittman last night ruled in favor of the Food and Drug Administration, denying the Outsourcing Facilities ...

Investing.com -- Hims & Hers Health shares are down over 8% premarket Thursday after a federal judge ruled in favor of the ...

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...

Morgan Stanley noted that two compounding groups – the Outsourcing Facilities Association and North American Custom Laboratories – filed a ...